Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français
BioSenic

New SOLUTIONS

for autoimmune and inflammatory diseases

Our Team
Technology
Investors
BioSenic

New SOLUTIONS

for autoimmune and inflammatory diseases

Our Team
Technology
Investors
BioSenic

New SOLUTIONS

for autoimmune and inflammatory diseases

Our Team
Technology
Investors

Our Executive Team

 Notre Équipe de direction

Products

BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.

Investors

All regulatory information and reports.

 

Clinical studies

Discover all the details of our clinical studies.

ERRATUM: BioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease

Arsenic Trioxide

An innovative drug to treat autoimmune diseases at the source of the immune cascade.

 

Our technology

BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.

 

Stock information

BioSenic ( BIOS )

0.065€

08.12.2023

Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions